Search
Search
Close this search box.

Canopy Growth Launches ‘Upsized’ $35m Private Raise

Canadian cannabis giant Canopy Growth announced plans to launch a new $35 million private fundraise as it continues efforts to reduce its debt obligations.

In what the company described as an ‘upsizing’, coming just days after it canceled a $30 million raise, Canopy said yesterday (January 18) that it had entered into subscription agreements ‘with certain institutional investors’.

Its offering will include 8.2 million units at a price of US$4.29 each, seeing it raise aggregate gross proceeds of ‘approximately’ $35 million.

Each unit will consist of one common share and either a Series A or Series B common share purchase warrant, entitling the holder to acquire one common share from the company at a price equal to $4.83. The placing is expected to close today (January 19).

According to the company, the fundraise will provide working capital for general purposes but is primarily expected to be used to ‘pay down debt, which is consistent with the Company’s strategy for overall debt reduction’.

In its latest financial report from November, Canopy said that it managed to reduce its overall debt from $364 million to $681 million in Q2 FY2024, seeing its total debt reduction top $1 billion since the beginning of FY2023.

⏰ Pre-order discount ends Jan 15
-- Days
-- Hours
-- Mins
Data packs delivered January 2026
🔬 New Report Due January 2026

Global Medical Cannabis Market Review 2026

A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.

What's covered

  • 📊 Global supply chain overview — understand export/import dynamics and domestic production capabilities
  • 🌍 8 export country snapshots — Canada, Portugal, Denmark, North Macedonia, Spain, Australia, Czech Republic, South Africa
  • 👥 6 patient market snapshots — Australia, Germany, UK, Poland, Brazil, France
  • 🔮 Key themes — Canada's global impact, telemedicine growth, new market openings, quota changes
Export Markets
🇨🇦 Canada 🇵🇹 Portugal 🇩🇰 Denmark 🇲🇰 N. Macedonia 🇪🇸 Spain 🇦🇺 Australia 🇨🇿 Czechia 🇿🇦 South Africa
Patient Markets
🇦🇺 Australia 🇩🇪 Germany 🇬🇧 UK 🇵🇱 Poland 🇧🇷 Brazil 🇫🇷 France
100% free • No credit card required
As trusted by
DIAGEO KPMG Coca-Cola BARCLAYS BNP PARIBAS AB InBev NOVARTIS Johnson & Johnson PEPSICO AXA POLITICO Bloomberg amazon CNN Business
Part of our annual market review series GDPR compliant

Related Posts

Related Posts

CONNECT

Related Posts

Related Posts

Recent Posts

Related Posts

Subscribe to our mailing list to receives daily updates!

We won’t spam you

Categories

Browse by Tags

CATEGORIES

EDITION

BUSINESS OF CANNABIS

© 2023 Prohibition Holdings Ltd. All Rights Reserved.

EDITION

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?